However, mutations in the genes KMT2A (MLL) and TP53 were more common in patients with PV (13.64% and 6.25%, respectively) than patients with PMF (3.45% and 0%, respectively) or ET (0% and 0%, respectively) [76]. The gene discussed is KMT2A; the disease is essential thrombocythemia.